Azenta, Inc.

AZTA Healthcare Medical Instruments & Supplies

Azenta, Inc.’s revenue for fiscal 2025 (year ended September 2025) was $593.8 million, up 3.55% from fiscal 2024. In the quarter to June 2026, revenue grew 12.0%, EPS grew 104.4% and free cash flow fell 134.7%, each against the same quarter a year earlier. Dividend growth for ten consecutive years, revenue growth for three, operating cash flow growth for three; insiders bought in the last twelve months.

34.09 2.43 −6.65%
Market cap
$1.6B
P/E
0.0×
Fwd P/E
−6.2×
Dividend yield
—
F-score
7/9
Altman Z
3.85
Beneish M
−2.63
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
0.00 0.00 0.00 0.00

+8 more quarters

P/S ratio
1.88 1.63 2.57 2.21
P/FCF ratio
116.96 32.39 49.39 34.28
P/Operating CF
799.79 72.03 73.28 605.41
P/B ratio
0.77 0.63 0.89 0.76
EV/Sales
1.43 1.07 1.96 1.72
EV/EBITDA
31.24 20.25 38.90 31.13
EV/FCF
88.82 21.32 37.69 26.63
Current Ratio
2.50 2.83 2.92 2.98
Net Debt/EBITDA
(36.48) 127.09 (68.25) (21.35)
Debt/Equity
0.00 0.00 0.00 0.00
Earnings Yield
(10.78%) (18.69%) (4.03%) (4.49%)
Free Cash Flow Yield
0.85% 3.09% 2.02% 2.92%
Free Cash Flow per Share
(0.11) 0.13 0.32 (0.12)
Book value per Share
33.35 33.75 37.34 37.75
Free Cash Flow
(5.19) 6.11 14.66 (5.69)
EV/EBIT
0.00 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates